CNS PHARMACEUTICALS INC's ticker is CNSP and the CUSIP is 18978H102.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $6,000 | -33.3% | 32,094 | 0.0% | 0.00% | – |
Q2 2022 | $9,000 | -18.2% | 32,094 | 0.0% | 0.00% | – |
Q1 2022 | $11,000 | -52.2% | 32,094 | 0.0% | 0.00% | – |
Q4 2021 | $23,000 | -52.1% | 32,094 | 0.0% | 0.00% | – |
Q3 2021 | $48,000 | -23.8% | 32,094 | 0.0% | 0.00% | – |
Q2 2021 | $63,000 | -18.2% | 32,094 | 0.0% | 0.00% | – |
Q1 2021 | $77,000 | – | 32,094 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Altium Capital Management LP | 534,148 | $951,000 | 0.36% |
CVI Holdings, LLC | 415,652 | $740,000 | 0.14% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 61,307 | $109,000 | 0.01% |
Warberg Asset Management LLC | 14,000 | $25,000 | 0.01% |
Alpha Cubed Investments, LLC | 10,000 | $18,000 | 0.00% |
Integrated Advisors Network LLC | 10,700 | $19,000 | 0.00% |
Core Wealth Advisors, Inc. | 550 | $1,000 | 0.00% |
OSAIC HOLDINGS, INC. | 5,000 | $9,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 41 | $0 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |